FDA approves 1st agitation drug for Alzheimer's patients
FDA approved the first drug to treat agitation associated with Alzheimer's disease: Rexulti, a brexpiprazole oral tablet
Stay updated with breaking news from Ssociated. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FDA approved the first drug to treat agitation associated with Alzheimer's disease: Rexulti, a brexpiprazole oral tablet
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 11.05.2023 / 18:00 CET/CEST The... | May 11, 2023
Obstructive sleep apnea is linked to an increased risk of long-term COVID
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 10.05.2023 / 10:14 CET/CEST The... | May 10, 2023
MyJournals.org - Science - 'Minimal change disease associated with thyroid cancer: a case report' (Frontiers in Medicine)